Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia

Megan R. Wimmer, Meggie Griffin, Alex Peterson-Weber,Lucas T. Schulz,Ashlee G. Hamel,Rebecca J. Schwei,Karen Fong,Donna R. Burgess,Meghan Brett,Cory M. Hale,Marisa Holubar,Rupali Jain, Rachel Larry,Emily S. Spivak,Helen Newland,Jessica Njoku,Michael Postelnick,Carla Walraven,Michael S. Pulia

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY（2024）

引用 0|浏览3

暂无评分

摘要

We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要